{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:51:51Z","timestamp":1781650311370,"version":"3.54.5"},"reference-count":226,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the internal funding project of Nanchang University","award":["2023efyBo5"],"award-info":[{"award-number":["2023efyBo5"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Colorectal cancer (CRC), as one of the malignant tumors with a high incidence globally, has a complex tumor micro-environment (TME) that plays a key role in tumorigenesis, progression, and treatment resistance. In recent years, liquid\u2013liquid phase separation (LLPS) of biomolecules has been gradually discovered to participate in regulating the dynamic balance of the stromal-immune axis in CRC as an important mechanism for integrating intracellular and extracellular signals. LLPS drives the formation of pathogenic aggregates, reshaping the functions of cancer-associated fibroblasts (CAFs), endothelial cells (ECs), and immune cells, promoting tumor cells to evade immune surveillance and forming an immunosuppressive microenvironment. Current research reveals the core role of LLPS in the malignant interactions between CRC stroma and immune cells, but how to precisely target these phase-separated aggregates remains a challenge. This article reviews the regulatory mechanisms of the stromal-immune axis mediated by LLPS, focusing on innovative therapeutic strategies based on small molecule inhibitors, protein degradation technologies, and nano-drug delivery systems, aiming to provide new theoretical basis and clinical translation directions for precise immunotherapy of CRC, and to promote overcoming the challenges of treatment resistance and recurrence.<\/jats:p>","DOI":"10.1186\/s12964-026-02849-5","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:25:48Z","timestamp":1776065148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting phase separation: a new strategy to disrupt the stromal-immune axis in colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Chenhao","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"4","key":"2849_CR1","first-page":"308","volume":"47","author":"JJ Li","year":"2025","unstructured":"Li JJ, et al. Comparison analyses of global burden of colorectal cancer. Zhonghua Zhong Liu Za Zhi. 2025;47(4):308\u201315.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"12","key":"2849_CR2","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/CM9.0000000000003140","volume":"137","author":"W Cao","year":"2024","unstructured":"Cao W, et al. Socioeconomic inequalities in cancer incidence and mortality: an analysis of GLOBOCAN 2022. Chin Med J (Engl). 2024;137(12):1407\u201313.","journal-title":"Chin Med J (Engl)"},{"issue":"16","key":"2849_CR3","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1097\/CM9.0000000000003225","volume":"137","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, et al. Burden of six major types of digestive system cancers globally and in China. Chin Med J (Engl). 2024;137(16):1957\u201364.","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"2849_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41574-025-01159-z","volume":"21","author":"M Du","year":"2025","unstructured":"Du M, et al. Early-onset colorectal cancer as an emerging disease of metabolic dysregulation. Nat Rev Endocrinol. 2025;21(11):686\u2013702.","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"2849_CR5","first-page":"631","volume":"40","author":"ZC Jiang","year":"2018","unstructured":"Jiang ZC, Chi Y. Data review and analysis of 22 cases of gastric cancer associated with pregnancy. Zhonghua Zhong Liu Za Zhi. 2018;40(8):631\u20135.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"1","key":"2849_CR6","first-page":"3","volume":"50","author":"M Mimeault","year":"2008","unstructured":"Mimeault M, Batra SK. Targeting of cancer stem\/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers. Panminerva Med. 2008;50(1):3\u201318.","journal-title":"Panminerva Med"},{"issue":"2","key":"2849_CR7","first-page":"285","volume":"57","author":"G Stamatis","year":"1990","unstructured":"Stamatis G, Niederle N, Greschuchna D. Interdisciplinary concepts and long-term results after surgery of pulmonary metastases. Helv Chir Acta. 1990;57(2):285\u201393.","journal-title":"Helv Chir Acta"},{"issue":"2","key":"2849_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1152\/physiolgenomics.00103.2023","volume":"56","author":"X Li","year":"2024","unstructured":"Li X, et al. Host-microbiota interactions contributing to the heterogeneous tumor microenvironment in colorectal cancer. Physiol Genomics. 2024;56(2):221\u201334.","journal-title":"Physiol Genomics"},{"key":"2849_CR9","doi-asserted-by":"publisher","first-page":"104946","DOI":"10.1016\/j.critrevonc.2025.104946","volume":"216","author":"A Zhang","year":"2025","unstructured":"Zhang A, et al. Molecular landscape of colorectal cancer liver metastasis: Tumor microenvironment heterogeneity and driver inference. Crit Rev Oncol Hematol. 2025;216:104946.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"2849_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41419-019-1435-2","volume":"10","author":"R Zhang","year":"2019","unstructured":"Zhang R, et al. Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer. Cell Death Dis. 2019;10(4):273.","journal-title":"Cell Death Dis"},{"issue":"6","key":"2849_CR11","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/cancers15061899","volume":"15","author":"K Wright","year":"2023","unstructured":"Wright K, et al. Cancer-associated fibroblasts: master tumor microenvironment modifiers. Cancers (Basel). 2023;15(6):1899.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2849_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2741\/3613","volume":"15","author":"F Xing","year":"2010","unstructured":"Xing F, Saidou J, Watabe K. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci (Landmark Ed). 2010;15(1):166\u201379.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"9","key":"2849_CR13","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/cancers12092652","volume":"12","author":"D Ganguly","year":"2020","unstructured":"Ganguly D, et al. Cancer-associated fibroblasts: versatile players in the tumor microenvironment. Cancers (Basel). 2020;12(9):2652.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2849_CR14","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/imcb.12054","volume":"96","author":"SM Toor","year":"2018","unstructured":"Toor SM, Elkord E. Therapeutic prospects of targeting myeloid-derived suppressor cells and immune checkpoints in cancer. Immunol Cell Biol. 2018;96(9):888\u201397.","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"2849_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/cancers13020210","volume":"13","author":"M Haist","year":"2021","unstructured":"Haist M, et al. The functional crosstalk between myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment. Cancers (Basel). 2021;13(2):210.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2849_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/vaccines4030028","volume":"4","author":"B Chaudhary","year":"2016","unstructured":"Chaudhary B, Elkord E. Regulatory T Cells in the tumor microenvironment and cancer progression: role and therapeutic targeting. Vaccines. 2016;4(3):28.","journal-title":"Vaccines"},{"issue":"6","key":"2849_CR17","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1021\/acs.biomac.5c00193","volume":"26","author":"NN Foressi","year":"2025","unstructured":"Foressi NN, et al. Cation-driven modulation of Tau condensates: insights into liquid-liquid phase separation and rheological properties. Biomacromol. 2025;26(6):3605\u201316.","journal-title":"Biomacromol"},{"issue":"11","key":"2849_CR18","doi-asserted-by":"publisher","first-page":"ae12a7","DOI":"10.1088\/1361-6633\/ae12a7","volume":"88","author":"D Zwicker","year":"2025","unstructured":"Zwicker D, Paulin O, Ter Burg C. Physics of droplet regulation in biological cells. Rep Prog Phys. 2025;88(11):ae12a7.","journal-title":"Rep Prog Phys"},{"key":"2849_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-0716-2663-4_10","volume":"2563","author":"L Zuo","year":"2023","unstructured":"Zuo L, Lai L, Qi Z. Single-molecule imaging of the phase separation-modulated DNA compaction to study transcriptional repression. Methods Mol Biol. 2023;2563:215\u201323.","journal-title":"Methods Mol Biol"},{"key":"2849_CR20","doi-asserted-by":"publisher","first-page":"216614","DOI":"10.1016\/j.canlet.2024.216614","volume":"584","author":"X Yan","year":"2024","unstructured":"Yan X, Zhang M, Wang D. Interplay between posttranslational modifications and liquid-liquid phase separation in tumors. Cancer Lett. 2024;584:216614.","journal-title":"Cancer Lett"},{"issue":"2","key":"2849_CR21","doi-asserted-by":"publisher","first-page":"e70122","DOI":"10.1111\/cpr.70122","volume":"59","author":"CC Xie","year":"2025","unstructured":"Xie CC, et al. Liquid-Liquid Phase Separation in Major Hallmarks of Cancer. Cell Prolif. 2025;59(2):e70122.","journal-title":"Cell Prolif"},{"issue":"1","key":"2849_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12964-024-01787-4","volume":"22","author":"X Zhang","year":"2024","unstructured":"Zhang X, et al. Emerging roles of liquid-liquid phase separation in liver innate immunity. Cell Commun Signal. 2024;22(1):430.","journal-title":"Cell Commun Signal"},{"issue":"20","key":"2849_CR23","doi-asserted-by":"publisher","first-page":"e2101895","DOI":"10.1002\/advs.202101895","volume":"8","author":"B Lu","year":"2021","unstructured":"Lu B, et al. Pharmacological inhibition of core regulatory circuitry liquid-liquid phase separation suppresses metastasis and chemoresistance in Osteosarcoma. Adv Sci (Weinh). 2021;8(20):e2101895.","journal-title":"Adv Sci (Weinh)"},{"key":"2849_CR24","doi-asserted-by":"publisher","first-page":"820174","DOI":"10.3389\/fcell.2021.820174","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, et al. Systematic analysis of molecular characterization and clinical relevance of liquid-liquid phase separation regulators in digestive system neoplasms. Front Cell Dev Biol. 2021;9:820174.","journal-title":"Front Cell Dev Biol"},{"key":"2849_CR25","doi-asserted-by":"publisher","first-page":"1694377","DOI":"10.3389\/fimmu.2025.1694377","volume":"16","author":"T Jiang","year":"2025","unstructured":"Jiang T, et al. A novel liquid-liquid phase separation related gene signature including ARL6IP4 predicts prognosis and immune landscape in colorectal cancer. Front Immunol. 2025;16:1694377.","journal-title":"Front Immunol"},{"key":"2849_CR26","doi-asserted-by":"publisher","first-page":"1678096","DOI":"10.3389\/fimmu.2025.1678096","volume":"16","author":"J Cheng","year":"2025","unstructured":"Cheng J, et al. Membraneless organelles-based integrative analysis constructs an immune-related prognostic signature and identifies NRG1 as a novel methylation biomarker in colorectal cancer. Front Immunol. 2025;16:1678096.","journal-title":"Front Immunol"},{"issue":"8","key":"2849_CR27","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1080\/15548627.2025.2481001","volume":"21","author":"B Chen","year":"2025","unstructured":"Chen B, et al. PTK6 drives HNRNPH1 phase separation to activate autophagy and suppress apoptosis in colorectal cancer. Autophagy. 2025;21(8):1680\u201399.","journal-title":"Autophagy"},{"issue":"10","key":"2849_CR28","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00109-022-02253-9","volume":"100","author":"N Huang","year":"2022","unstructured":"Huang N, Dong H, Shao B. Phase separation in immune regulation and immune-related diseases. J Mol Med (Berl). 2022;100(10):1427\u201340.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"2849_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13045-023-01522-5","volume":"16","author":"LW Zheng","year":"2023","unstructured":"Zheng LW, Liu CC, Yu KD. Phase separations in oncogenesis, tumor progressions and metastasis: a glance from hallmarks of cancer. J Hematol Oncol. 2023;16(1):123.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"2849_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cell.2020.09.002","volume":"183","author":"G Zhu","year":"2020","unstructured":"Zhu G, et al. Phase separation of disease-associated SHP2 mutants underlies MAPK hyperactivation. Cell. 2020;183(2):490-502.e18.","journal-title":"Cell"},{"issue":"6","key":"2849_CR31","first-page":"1527","volume":"55","author":"J Li","year":"2024","unstructured":"Li J, Zhou C. Latest findings on the role of liquid-liquid phase separation in the regulation of immune cell activation and key signaling. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024;55(6):1527\u201332.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"42","key":"2849_CR32","doi-asserted-by":"publisher","first-page":"e2219589120","DOI":"10.1073\/pnas.2219589120","volume":"120","author":"T Zhu","year":"2023","unstructured":"Zhu T, et al. Phase separation underlies signaling activation of oncogenic NTRK fusions. Proc Natl Acad Sci U S A. 2023;120(42):e2219589120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2849_CR33","first-page":"943","volume":"43","author":"T Deng","year":"2023","unstructured":"Deng T, Du B, Xi X. Colorectal cancer cells induce the formation of cancer-associated fibroblasts by activating the ERK signaling pathway in fibroblasts. Nan Fang Yi Ke Da Xue Xue Bao. 2023;43(6):943\u201351.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"1","key":"2849_CR34","doi-asserted-by":"publisher","first-page":"6966","DOI":"10.1038\/s41467-023-42382-4","volume":"14","author":"J Barbazan","year":"2023","unstructured":"Barbazan J, et al. Cancer-associated fibroblasts actively compress cancer cells and modulate mechanotransduction. Nat Commun. 2023;14(1):6966.","journal-title":"Nat Commun"},{"issue":"1","key":"2849_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/biom13010067","volume":"13","author":"JS Owen","year":"2022","unstructured":"Owen JS, Clayton A, Pearson HB. Cancer-associated fibroblast heterogeneity, activation and function: implications for prostate cancer. Biomolecules. 2022;13(1):67.","journal-title":"Biomolecules"},{"issue":"10","key":"2849_CR36","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1038\/s12276-025-01551-9","volume":"57","author":"HS Kim","year":"2025","unstructured":"Kim HS, Nam JS. The multifaceted role of YAP in the tumor microenvironment and its therapeutic implications in cancer. Exp Mol Med. 2025;57(10):2201\u201313.","journal-title":"Exp Mol Med"},{"issue":"7","key":"2849_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41419-023-05965-z","volume":"14","author":"G Lu","year":"2023","unstructured":"Lu G, et al. Cancer associated fibroblast derived SLIT2 drives gastric cancer cell metastasis by activating NEK9. Cell Death Dis. 2023;14(7):421.","journal-title":"Cell Death Dis"},{"issue":"11","key":"2849_CR38","doi-asserted-by":"publisher","first-page":"e013175","DOI":"10.1136\/jitc-2025-013175","volume":"13","author":"F Li","year":"2025","unstructured":"Li F, et al. Oncolytic virus-induced IL-1\u03b2(+) monocyte-IL-6(+) CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer. J Immunother Cancer. 2025;13(11):e013175.","journal-title":"J Immunother Cancer"},{"key":"2849_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.canlet.2021.06.009","volume":"518","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, et al. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6\/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma. Cancer Lett. 2021;518:35\u201348.","journal-title":"Cancer Lett"},{"issue":"16","key":"2849_CR40","doi-asserted-by":"publisher","first-page":"e12627","DOI":"10.1002\/advs.202512627","volume":"13","author":"W Xia","year":"2026","unstructured":"Xia W, et al. PBRM1 deficiency reshapes an immune suppressive microenvironment through epigenetic tuning of PBRM1-KDM5C-IL6 Axis in ccRCC. Advanced Science. 2026;13(16):e12627.","journal-title":"Advanced Science"},{"issue":"2","key":"2849_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/cancers16020449","volume":"16","author":"RA Glabman","year":"2024","unstructured":"Glabman RA, et al. Tumor suppression by anti-fibroblast activation protein near-infrared photoimmunotherapy targeting cancer-associated fibroblasts. Cancers (Basel). 2024;16(2):449.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2849_CR42","doi-asserted-by":"publisher","first-page":"e008721","DOI":"10.1136\/jitc-2023-008721","volume":"12","author":"H Wang","year":"2024","unstructured":"Wang H, et al. POSTN(+) cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma. J Immunother Cancer. 2024;12(7):e008721.","journal-title":"J Immunother Cancer"},{"issue":"20","key":"2849_CR43","doi-asserted-by":"publisher","first-page":"e163022","DOI":"10.1172\/jci.insight.163022","volume":"8","author":"F Kitamura","year":"2023","unstructured":"Kitamura F, et al. Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer. JCI Insight. 2023;8(20):e163022.","journal-title":"JCI Insight"},{"issue":"17","key":"2849_CR44","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.7150\/thno.75853","volume":"12","author":"Q Li","year":"2022","unstructured":"Li Q, et al. Enhancer reprogramming promotes the activation of cancer-associated fibroblasts and breast cancer metastasis. Theranostics. 2022;12(17):7491\u2013508.","journal-title":"Theranostics"},{"key":"2849_CR45","doi-asserted-by":"publisher","first-page":"214061","DOI":"10.1016\/j.bioadv.2024.214061","volume":"166","author":"G Rub\u00ed-Sans","year":"2025","unstructured":"Rub\u00ed-Sans G, et al. Substrate stiffness-dependent activation of Hippo pathway in cancer associated fibroblasts. Biomater Adv. 2025;166:214061.","journal-title":"Biomater Adv"},{"key":"2849_CR46","doi-asserted-by":"crossref","unstructured":"Wang J et al. Nuclear force transmission drives cancer-associated fibroblast activation under BRAF inhibition. bioRxiv. 2025.","DOI":"10.1101\/2025.07.19.665630"},{"issue":"712","key":"2849_CR47","doi-asserted-by":"publisher","first-page":"eabj8393","DOI":"10.1126\/scisignal.abj8393","volume":"14","author":"Y Shen","year":"2021","unstructured":"Shen Y, et al. STAT3-YAP\/TAZ signaling in endothelial cells promotes tumor angiogenesis. Sci Signal. 2021;14(712):eabj8393.","journal-title":"Sci Signal"},{"issue":"2","key":"2849_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1053\/j.gastro.2024.10.004","volume":"168","author":"M Rathore","year":"2025","unstructured":"Rathore M, et al. Leucine-Rich Alpha-2-glycoprotein 1 promotes metastatic colorectal cancer growth through human epidermal growth factor receptor 3 signaling. Gastroenterology. 2025;168(2):300-315.e3.","journal-title":"Gastroenterology"},{"issue":"10","key":"2849_CR49","doi-asserted-by":"publisher","first-page":"e144225","DOI":"10.1172\/JCI144225","volume":"131","author":"Z Lu","year":"2021","unstructured":"Lu Z, et al. Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapies. J Clin Invest. 2021;131(10):e144225.","journal-title":"J Clin Invest"},{"issue":"4","key":"2849_CR50","doi-asserted-by":"publisher","first-page":"e70313","DOI":"10.1002\/ctm2.70313","volume":"15","author":"S Yang","year":"2025","unstructured":"Yang S, et al. Angiogenesis and targeted therapy in the tumour microenvironment: from basic to clinical practice. Clin Transl Med. 2025;15(4):e70313.","journal-title":"Clin Transl Med"},{"issue":"7","key":"2849_CR51","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.3390\/ijms26072919","volume":"26","author":"M Tanaka","year":"2025","unstructured":"Tanaka M, et al. Lymphangiogenesis in the deepest invasive areas of human early-stage colorectal cancer. Int J Mol Sci. 2025;26(7):2912.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2849_CR52","doi-asserted-by":"publisher","first-page":"101611","DOI":"10.1016\/j.gendis.2025.101611","volume":"12","author":"Y Han","year":"2025","unstructured":"Han Y, Zhu B, Meng S. Endothelial cell in tumor angiogenesis: origins, mechanisms, and therapeutic implication. Genes & Diseases. 2025;12(6):101611.","journal-title":"Genes & Diseases"},{"issue":"9","key":"2849_CR53","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1080\/1061186X.2025.2508985","volume":"33","author":"SX Yao","year":"2025","unstructured":"Yao SX, et al. Revisiting VEGF\/VEGFR-2 signalling as an anticancer target and its inhibitor discovery: where are we and where should we go? J Drug Target. 2025;33(9):1471\u201394.","journal-title":"J Drug Target"},{"issue":"20","key":"2849_CR54","doi-asserted-by":"publisher","first-page":"11284","DOI":"10.3390\/ijms252011284","volume":"25","author":"J Lidonnici","year":"2024","unstructured":"Lidonnici J, Oberkersch RE. Reciprocal dynamics of metabolism and mRNA translation in tumor angiogenesis. Int J Mol Sci. 2024;25(20):11284.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"2849_CR55","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.7150\/thno.113665","volume":"15","author":"Y Fang","year":"2025","unstructured":"Fang Y, et al. Breaking the premetastatic niche barrier: the role of endothelial cells and therapeutic strategies. Theranostics. 2025;15(13):6454\u201375.","journal-title":"Theranostics"},{"key":"2849_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-3-030-34025-4_8","volume":"1219","author":"F Lopes-Coelho","year":"2020","unstructured":"Lopes-Coelho F, Martins F, Serpa J. Endothelial cells (ECs) metabolism: a valuable piece to disentangle cancer biology. Adv Exp Med Biol. 2020;1219:143\u201359.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"2849_CR57","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s12265-024-10485-y","volume":"17","author":"Y Cai","year":"2024","unstructured":"Cai Y, et al. Therapeutic strategies for angiogenesis based on endothelial cell epigenetics. J Cardiovasc Transl Res. 2024;17(4):816\u201327.","journal-title":"J Cardiovasc Transl Res"},{"issue":"39","key":"2849_CR58","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1038\/s41388-025-03498-7","volume":"44","author":"Y Ren","year":"2025","unstructured":"Ren Y, et al. Liquid-liquid phase separation of GPS2-LATS1 promotes colorectal cancer progression by reprogramming lipid metabolism. Oncogene. 2025;44(39):3741\u201354.","journal-title":"Oncogene"},{"issue":"1","key":"2849_CR59","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/s41467-025-68209-y","volume":"17","author":"J Shi","year":"2026","unstructured":"Shi J, et al. Volumetric compression regulates the phase separation of AXIN and acts as an operational amplifier to bidirectionally modulate Wnt signaling in organoids. Nat Commun. 2026;17(1):1471.","journal-title":"Nat Commun"},{"issue":"1","key":"2849_CR60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/CIRCRESAHA.122.322113","volume":"132","author":"J Liu","year":"2023","unstructured":"Liu J, et al. Liquid-liquid phase separation of DDR1 counteracts the Hippo pathway to orchestrate arterial stiffening. Circ Res. 2023;132(1):87\u2013105.","journal-title":"Circ Res"},{"issue":"2","key":"2849_CR61","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/JLB.5MR0320-205R","volume":"108","author":"E Russo","year":"2020","unstructured":"Russo E, Santoni A, Bernardini G. Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer. J Leukoc Biol. 2020;108(2):673\u201385.","journal-title":"J Leukoc Biol"},{"issue":"20","key":"2849_CR62","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1039\/D3BM00573A","volume":"11","author":"S Duarte-Sanmiguel","year":"2023","unstructured":"Duarte-Sanmiguel S, et al. ICAM-1-decorated extracellular vesicles loaded with miR-146a and Glut1 drive immunomodulation and hinder tumor progression in a murine model of breast cancer. Biomater Sci. 2023;11(20):6834\u201347.","journal-title":"Biomater Sci"},{"key":"2849_CR63","doi-asserted-by":"publisher","first-page":"114504","DOI":"10.1016\/j.biopha.2023.114504","volume":"161","author":"L Li","year":"2023","unstructured":"Li L, Tian Y. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment. Biomed Pharmacother. 2023;161:114504.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2849_CR64","first-page":"133","volume":"33","author":"J Choi","year":"2018","unstructured":"Choi J, et al. The role of tumor-associated macrophage in breast cancer biology. Histol Histopathol. 2018;33(2):133\u201345.","journal-title":"Histol Histopathol"},{"key":"2849_CR65","doi-asserted-by":"publisher","first-page":"1573917","DOI":"10.3389\/fimmu.2025.1573917","volume":"16","author":"J Xiang","year":"2025","unstructured":"Xiang J, et al. Targeting tumor-associated macrophages in colon cancer: mechanisms and therapeutic strategies. Front Immunol. 2025;16:1573917.","journal-title":"Front Immunol"},{"issue":"11","key":"2849_CR66","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.drudis.2018.05.016","volume":"23","author":"L Singh","year":"2018","unstructured":"Singh L, et al. Prolyl hydroxylase 2: a promising target to inhibit hypoxia-induced cellular metabolism in cancer cells. Drug Discov Today. 2018;23(11):1873\u201382.","journal-title":"Drug Discov Today"},{"issue":"8","key":"2849_CR67","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41556-023-01185-x","volume":"25","author":"L Zhang","year":"2023","unstructured":"Zhang L, et al. STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2. Nat Cell Biol. 2023;25(8):1208\u201322.","journal-title":"Nat Cell Biol"},{"issue":"16","key":"2849_CR68","doi-asserted-by":"publisher","first-page":"e2407458","DOI":"10.1002\/advs.202407458","volume":"12","author":"J Fernandez Alarcon","year":"2025","unstructured":"Fernandez Alarcon J, et al. Functional polarization of liver macrophages by Glyco Gold nanoparticles. Adv Sci (Weinh). 2025;12(16):e2407458.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2849_CR69","doi-asserted-by":"publisher","first-page":"e003131","DOI":"10.1136\/jitc-2021-003131","volume":"10","author":"S Zilio","year":"2022","unstructured":"Zilio S, et al. CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor. J Immunother Cancer. 2022;10(1):e003131.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"2849_CR70","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/gutjnl-2024-332193","volume":"74","author":"Q Zhou","year":"2025","unstructured":"Zhou Q, et al. Microbiota-induced S100A11-RAGE axis underlies immune evasion in right-sided colon adenomas and is a therapeutic target to boost anti-PD1 efficacy. Gut. 2025;74(2):214\u201328.","journal-title":"Gut"},{"issue":"10","key":"2849_CR71","doi-asserted-by":"publisher","first-page":"e70411","DOI":"10.1002\/mco2.70411","volume":"6","author":"D Zhou","year":"2025","unstructured":"Zhou D, et al. Cholesterol 25-Hydroxylase Enhances Myeloid-Derived Suppressor Cell (MDSC) Immunosuppression via the Stimulator of Interferon Genes (STING)-Tank-Binding Kinase 1 (TBK1)-Receptor-Interacting Protein Kinase 3 (RIPK3) Pathway in Colorectal Cancer. MedComm (2020). 2025;6(10):e70411.","journal-title":"MedComm (2020)"},{"issue":"72","key":"2849_CR72","doi-asserted-by":"publisher","first-page":"eabn0175","DOI":"10.1126\/sciimmunol.abn0175","volume":"7","author":"E Jou","year":"2022","unstructured":"Jou E, et al. An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis. Science Immunology. 2022;7(72):eabn0175.","journal-title":"Science Immunology"},{"issue":"3","key":"2849_CR73","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s43018-023-00691-z","volume":"5","author":"C Huang","year":"2024","unstructured":"Huang C, et al. Sirp\u03b1 on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47. Nat Cancer. 2024;5(3):500\u201316.","journal-title":"Nat Cancer"},{"issue":"1","key":"2849_CR74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12964-023-01380-1","volume":"22","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Crosstalk between protein post-translational modifications and phase separation. Cell Commun Signal. 2024;22(1):110.","journal-title":"Cell Commun Signal"},{"issue":"18","key":"2849_CR75","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1074\/jbc.TM118.001189","volume":"294","author":"M Hofweber","year":"2019","unstructured":"Hofweber M, Dormann D. Friend or foe-post-translational modifications as regulators of phase separation and RNP granule dynamics. J Biol Chem. 2019;294(18):7137\u201350.","journal-title":"J Biol Chem"},{"issue":"13","key":"2849_CR76","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.3390\/ijms20133322","volume":"20","author":"MD Fulton","year":"2019","unstructured":"Fulton MD, Brown T, Zheng YG. The biological axis of protein arginine methylation and asymmetric dimethylarginine. Int J Mol Sci. 2019;20(13):3322.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2849_CR77","doi-asserted-by":"publisher","first-page":"e70425","DOI":"10.1002\/ctm2.70425","volume":"15","author":"T Jia","year":"2025","unstructured":"Jia T, et al. Multi-omics profiling identifies TNFRSF18 as a novel marker of exhausted CD8\u207a T cells and reveals tumour-immune dynamics in colorectal cancer. Clin Transl Med. 2025;15(8):e70425.","journal-title":"Clin Transl Med"},{"issue":"6285","key":"2849_CR78","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.aad9964","volume":"352","author":"X Su","year":"2016","unstructured":"Su X, et al. Phase separation of signaling molecules promotes T cell receptor signal transduction. Science. 2016;352(6285):595\u20139.","journal-title":"Science"},{"key":"2849_CR79","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/978-1-0716-3393-9_20","volume":"2705","author":"L Zeng","year":"2023","unstructured":"Zeng L, Su X. Biomolecular condensation of SH2 domain-containing proteins on membranes. Methods Mol Biol. 2023;2705:371\u20139.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"2849_CR80","doi-asserted-by":"publisher","first-page":"e202009154","DOI":"10.1083\/jcb.202009154","volume":"220","author":"L Zeng","year":"2021","unstructured":"Zeng L, et al. PLC\u03b31 promotes phase separation of T cell signaling components. J Cell Biol. 2021;220(6):e202009154.","journal-title":"J Cell Biol"},{"issue":"5","key":"2849_CR81","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10585-022-10172-9","volume":"39","author":"SU Khan","year":"2022","unstructured":"Khan SU, Fatima K, Malik F. Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis. Clin Exp Metastasis. 2022;39(5):715\u201326.","journal-title":"Clin Exp Metastasis"},{"key":"2849_CR82","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fimmu.2015.00141","volume":"6","author":"MY Bilal","year":"2015","unstructured":"Bilal MY, Houtman JC. GRB2 nucleates T cell receptor-mediated LAT clusters that control PLC-\u03b31 activation and cytokine production. Front Immunol. 2015;6:141.","journal-title":"Front Immunol"},{"key":"2849_CR83","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejca.2021.08.003","volume":"157","author":"X Zhu","year":"2021","unstructured":"Zhu X, et al. Overexpression of transposable elements is associated with immune evasion and poor outcome in colorectal cancer. Eur J Cancer. 2021;157:94\u2013107.","journal-title":"Eur J Cancer"},{"key":"2849_CR84","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2021.06.025","volume":"518","author":"H Zhang","year":"2021","unstructured":"Zhang H, et al. Intracellular AGR2 transduces PGE2 stimuli to promote epithelial-mesenchymal transition and metastasis of colorectal cancer. Cancer Lett. 2021;518:180\u201395.","journal-title":"Cancer Lett"},{"issue":"4","key":"2849_CR85","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1053\/j.gastro.2019.11.013","volume":"158","author":"B Cen","year":"2020","unstructured":"Cen B, et al. Prostaglandin E(2) induces miR675-5p to promote colorectal tumor metastasis via modulation of p53 expression. Gastroenterology. 2020;158(4):971-984.e10.","journal-title":"Gastroenterology"},{"issue":"1","key":"2849_CR86","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00262-019-02437-2","volume":"69","author":"Y Romero","year":"2020","unstructured":"Romero Y, Wise R, Zolkiewska A. Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells. Cancer Immunol Immunother. 2020;69(1):43\u201355.","journal-title":"Cancer Immunol Immunother"},{"issue":"21","key":"2849_CR87","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.3390\/ijms20215347","volume":"20","author":"J Litak","year":"2019","unstructured":"Litak J, et al. PD-L1\/PD-1 axis in glioblastoma multiforme. Int J Mol Sci. 2019;20(21):5347.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2849_CR88","first-page":"1553","volume":"5","author":"H Yamane","year":"2015","unstructured":"Yamane H, et al. Programmed cell death protein 1 and programmed death-ligand 1 are expressed on the surface of some small-cell lung cancer lines. Am J Cancer Res. 2015;5(4):1553\u20137.","journal-title":"Am J Cancer Res"},{"issue":"8036","key":"2849_CR89","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41586-024-07992-y","volume":"634","author":"H Li","year":"2024","unstructured":"Li H, et al. AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature. 2024;634(8036):1229\u201337.","journal-title":"Nature"},{"issue":"4","key":"2849_CR90","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s13238-012-2919-3","volume":"3","author":"H Liu","year":"2012","unstructured":"Liu H, et al. The hippo pathway regulates stem cell proliferation, self-renewal, and differentiation. Protein Cell. 2012;3(4):291\u2013304.","journal-title":"Protein Cell"},{"issue":"2","key":"2849_CR91","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.bbagen.2012.07.005","volume":"1830","author":"SE Hiemer","year":"2013","unstructured":"Hiemer SE, Varelas X. Stem cell regulation by the hippo pathway. Biochim Biophys Acta. 2013;1830(2):2323\u201334.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"2849_CR92","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1101\/gad.219402.113","volume":"27","author":"FX Yu","year":"2013","unstructured":"Yu FX, et al. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 2013;27(11):1223\u201332.","journal-title":"Genes Dev"},{"issue":"4","key":"2849_CR93","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3892\/or.2023.8615","volume":"50","author":"MK Sim","year":"2023","unstructured":"Sim MK, et al. Neuromedin U contributes to radiation resistance in colorectal cancer via YAP\/TAZ signaling activation. Oncol Rep. 2023;50(4):178.","journal-title":"Oncol Rep"},{"issue":"1","key":"2849_CR94","doi-asserted-by":"publisher","first-page":"e22688","DOI":"10.1096\/fj.202201181R","volume":"37","author":"W Liang","year":"2023","unstructured":"Liang W, et al. VASN promotes colorectal cancer progression by activating the YAP\/TAZ and AKT signaling pathways via YAP. FASEB J. 2023;37(1):e22688.","journal-title":"FASEB J"},{"key":"2849_CR95","doi-asserted-by":"publisher","first-page":"1126119","DOI":"10.3389\/fphar.2023.1126119","volume":"14","author":"W Otkur","year":"2023","unstructured":"Otkur W, et al. GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP\/TAZ activity in colorectal cancer cells. Front Pharmacol. 2023;14:1126119.","journal-title":"Front Pharmacol"},{"key":"2849_CR96","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.2147\/OTT.S231010","volume":"13","author":"C Liu","year":"2020","unstructured":"Liu C, Pei H, Tan F. Matrix stiffness and colorectal cancer. Onco Targets Ther. 2020;13:2747\u201355.","journal-title":"Onco Targets Ther"},{"key":"2849_CR97","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/1471-2407-11-245","volume":"11","author":"HO Lee","year":"2011","unstructured":"Lee HO, et al. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer. 2011;11:245.","journal-title":"BMC Cancer"},{"key":"2849_CR98","doi-asserted-by":"publisher","first-page":"123209","DOI":"10.1016\/j.biomaterials.2025.123209","volume":"320","author":"R Rao","year":"2025","unstructured":"Rao R, et al. Mechanical confinement triggers spreading and migration of immobile cells by deforming nucleus. Biomaterials. 2025;320:123209.","journal-title":"Biomaterials"},{"issue":"1","key":"2849_CR99","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11033-025-10264-1","volume":"52","author":"PD Talukdar","year":"2025","unstructured":"Talukdar PD, Roy H, Chatterji U. Targeting breast cancer stem cells in ER-positive breast cancer by repurposing the benzoporphyrin derivative verteporfin as a YAP\/TAZ small molecule inhibitor. Mol Biol Rep. 2025;52(1):154.","journal-title":"Mol Biol Rep"},{"issue":"13","key":"2849_CR100","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2217\/fon-2019-0035","volume":"15","author":"Z Tang","year":"2019","unstructured":"Tang Z, et al. A brief review: some compounds targeting YAP against malignancies. Future Oncol. 2019;15(13):1535\u201343.","journal-title":"Future Oncol"},{"key":"2849_CR101","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000092506","volume":"1","author":"P Alberici","year":"2006","unstructured":"Alberici P, Fodde R. The role of the APC tumor suppressor in chromosomal instability. Genome Dyn. 2006;1:149\u201370.","journal-title":"Genome Dyn"},{"issue":"10","key":"2849_CR102","doi-asserted-by":"publisher","first-page":"e2100138","DOI":"10.1002\/bies.202100138","volume":"43","author":"Q Shi","year":"2021","unstructured":"Shi Q, Kang K, Chen YG. Liquid-liquid phase separation drives the \u03b2-catenin destruction complex formation. BioEssays. 2021;43(10):e2100138.","journal-title":"BioEssays"},{"issue":"4","key":"2849_CR103","doi-asserted-by":"publisher","first-page":"e202012112","DOI":"10.1083\/jcb.202012112","volume":"220","author":"J Nong","year":"2021","unstructured":"Nong J, et al. Phase separation of Axin organizes the \u03b2-catenin destruction complex. J Cell Biol. 2021;220(4):e202012112.","journal-title":"J Cell Biol"},{"issue":"18","key":"2849_CR104","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1093\/hmg\/ddr273","volume":"20","author":"J Schneikert","year":"2011","unstructured":"Schneikert J, Brauburger K, Behrens J. APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC. Hum Mol Genet. 2011;20(18):3554\u201364.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"2849_CR105","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1038\/onc.2009.447","volume":"29","author":"EM Kohler","year":"2010","unstructured":"Kohler EM, et al. Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients. Oncogene. 2010;29(11):1663\u201371.","journal-title":"Oncogene"},{"issue":"12","key":"2849_CR106","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/onc.2009.457","volume":"29","author":"AF Cheung","year":"2010","unstructured":"Cheung AF, et al. Complete deletion of Apc results in severe polyposis in mice. Oncogene. 2010;29(12):1857\u201364.","journal-title":"Oncogene"},{"issue":"1-2","key":"2849_CR107","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1023\/A:1025858928620","volume":"23","author":"ML Waterman","year":"2004","unstructured":"Waterman ML. Lymphoid enhancer factor\/T cell factor expression in colorectal cancer. Cancer Metastasis Rev. 2004;23(1\u20132):41\u201352.","journal-title":"Cancer Metastasis Rev"},{"key":"2849_CR108","first-page":"255","volume":"43","author":"X Lu","year":"2025","unstructured":"Lu X, et al. Self-assembled PROTACs enable protein degradation to reprogram the tumor microenvironment for synergistically enhanced colorectal cancer immunotherapy. Bioact Mater. 2025;43:255\u201372.","journal-title":"Bioact Mater"},{"issue":"24","key":"2849_CR109","doi-asserted-by":"publisher","first-page":"13231","DOI":"10.3390\/ijms222413232","volume":"22","author":"W Zheng","year":"2021","unstructured":"Zheng W, et al. How the innate immune DNA sensing cGAS-STING pathway is involved in autophagy. Int J Mol Sci. 2021;22(24):13231.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2849_CR110","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.3390\/ijms24033029","volume":"24","author":"W Zheng","year":"2023","unstructured":"Zheng W, et al. How the innate immune DNA Sensing cGAS-STING pathway is involved in apoptosis. Int J Mol Sci. 2023;24(3):3029.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2849_CR111","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12943-025-02380-0","volume":"24","author":"Q Wang","year":"2025","unstructured":"Wang Q, et al. Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment. Mol Cancer. 2025;24(1):178.","journal-title":"Mol Cancer"},{"issue":"6403","key":"2849_CR112","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1126\/science.aat1022","volume":"361","author":"M Du","year":"2018","unstructured":"Du M, Chen ZJ. DNA-induced liquid phase condensation of cGAS activates innate immune signaling. Science. 2018;361(6403):704\u20139.","journal-title":"Science"},{"issue":"3","key":"2849_CR113","doi-asserted-by":"publisher","first-page":"e2411659122","DOI":"10.1073\/pnas.2411659122","volume":"122","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, et al. Crucial role of the cGAS N terminus in mediating flowable and functional cGAS-DNA condensate formation via DNA interactions. Proc Natl Acad Sci U S A. 2025;122(3):e2411659122.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"2849_CR114","first-page":"3261","volume":"186","author":"Y Li","year":"2023","unstructured":"Li Y, et al. cGLRs are a diverse family of pattern recognition receptors in animal innate immunity. bioRxiv. 2023;186(15):3261-3276.e20.","journal-title":"bioRxiv"},{"issue":"1","key":"2849_CR115","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.chom.2018.05.007","volume":"24","author":"ZF Huang","year":"2018","unstructured":"Huang ZF, et al. Human cytomegalovirus protein UL31 inhibits DNA sensing of cGAS to mediate immune evasion. Cell Host Microbe. 2018;24(1):69-80.e4.","journal-title":"Cell Host Microbe"},{"key":"2849_CR116","doi-asserted-by":"publisher","first-page":"1186916","DOI":"10.3389\/fimmu.2023.1186916","volume":"14","author":"S Hao","year":"2023","unstructured":"Hao S, et al. African swine fever virus QP383R dampens type I interferon production by promoting cGAS palmitoylation. Front Immunol. 2023;14:1186916.","journal-title":"Front Immunol"},{"issue":"9","key":"2849_CR117","first-page":"950","volume":"50","author":"S Nakajima","year":"2023","unstructured":"Nakajima S, Kaneta A, Kono K. [The Potential of a Novel Therapeutic Strategy for Colorectal Cancer Targeting the cGAS-STING Pathway]. Gan To Kagaku Ryoho. 2023;50(9):950\u20134.","journal-title":"Gan To Kagaku Ryoho"},{"issue":"1","key":"2849_CR118","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1186\/s12967-025-06566-4","volume":"23","author":"S Yan","year":"2025","unstructured":"Yan S, et al. p53 in colorectal cancer: from a master player to a privileged therapy target. J Transl Med. 2025;23(1):684.","journal-title":"J Transl Med"},{"issue":"50","key":"2849_CR119","doi-asserted-by":"publisher","first-page":"eads0427","DOI":"10.1126\/sciadv.ads0427","volume":"10","author":"D Datta","year":"2024","unstructured":"Datta D, et al. Nucleo-cytoplasmic environment modulates spatiotemporal p53 phase separation. Sci Adv. 2024;10(50):eads0427.","journal-title":"Sci Adv"},{"issue":"6","key":"2849_CR120","doi-asserted-by":"publisher","first-page":"692","DOI":"10.21037\/tcr.2016.11.76","volume":"5","author":"MW Braun","year":"2016","unstructured":"Braun MW, Iwakuma T. Regulation of cytotoxic T-cell responses by p53 in cancer. Transl Cancer Res. 2016;5(6):692\u20137.","journal-title":"Transl Cancer Res"},{"key":"2849_CR121","doi-asserted-by":"publisher","first-page":"1470328","DOI":"10.3389\/fimmu.2024.1470328","volume":"15","author":"L Liu","year":"2024","unstructured":"Liu L, et al. DNp73 enhances tumor progression and immune evasion in multiple myeloma by targeting the MYC and MYCN pathways. Front Immunol. 2024;15:1470328.","journal-title":"Front Immunol"},{"issue":"11","key":"2849_CR122","doi-asserted-by":"publisher","first-page":"e007479","DOI":"10.1136\/jitc-2023-007479","volume":"11","author":"J Yu","year":"2023","unstructured":"Yu J, et al. TP53\/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma. J Immunother Cancer. 2023;11(11):e007479.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2849_CR123","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.1038\/s41467-021-27142-6","volume":"12","author":"O Degtjarik","year":"2021","unstructured":"Degtjarik O, et al. Structural basis of reactivation of oncogenic p53 mutants by a small molecule: methylene quinuclidinone (MQ). Nat Commun. 2021;12(1):7057.","journal-title":"Nat Commun"},{"issue":"2","key":"2849_CR124","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/joim.12336","volume":"277","author":"J Zawacka-Pankau","year":"2015","unstructured":"Zawacka-Pankau J, Selivanova G. Pharmacological reactivation of p53 as a strategy to treat cancer. J Intern Med. 2015;277(2):248\u201359.","journal-title":"J Intern Med"},{"issue":"30","key":"2849_CR125","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1038\/onc.2010.188","volume":"29","author":"KG Wiman","year":"2010","unstructured":"Wiman KG. Pharmacological reactivation of mutant p53: from protein structure to the cancer patient. Oncogene. 2010;29(30):4245\u201352.","journal-title":"Oncogene"},{"issue":"20","key":"2849_CR126","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1158\/0008-5472.CAN-10-1073","volume":"70","author":"Y Li","year":"2010","unstructured":"Li Y, et al. Carcinoembryonic antigen interacts with TGF-{beta} receptor and inhibits TGF-{beta} signaling in colorectal cancers. Cancer Res. 2010;70(20):8159\u201368.","journal-title":"Cancer Res"},{"issue":"1","key":"2849_CR127","doi-asserted-by":"publisher","first-page":"14357","DOI":"10.1038\/s41598-023-41550-2","volume":"13","author":"H Jamialahmadi","year":"2023","unstructured":"Jamialahmadi H, et al. Targeting transforming growth factor beta (TGF-\u03b2) using Pirfenidone, a potential repurposing therapeutic strategy in colorectal cancer. Sci Rep. 2023;13(1):14357.","journal-title":"Sci Rep"},{"key":"2849_CR128","doi-asserted-by":"publisher","first-page":"657984","DOI":"10.3389\/fonc.2021.657984","volume":"11","author":"X Hu","year":"2021","unstructured":"Hu X, et al. Identification of target PTEN-based miR-425 and miR-576 as potential diagnostic and immunotherapeutic biomarkers of colorectal cancer with liver metastasis. Front Oncol. 2021;11:657984.","journal-title":"Front Oncol"},{"key":"2849_CR129","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-60761-738-9_5","volume":"647","author":"DA Chapnick","year":"2010","unstructured":"Chapnick DA, Liu X. Analysis of ligand-dependent nuclear accumulation of Smads in TGF-beta signaling. Methods Mol Biol. 2010;647:95\u2013111.","journal-title":"Methods Mol Biol"},{"issue":"52","key":"2849_CR130","doi-asserted-by":"publisher","first-page":"51008","DOI":"10.1074\/jbc.M208532200","volume":"277","author":"GJ Inman","year":"2002","unstructured":"Inman GJ, Hill CS. Stoichiometry of active smad-transcription factor complexes on DNA. J Biol Chem. 2002;277(52):51008\u201316.","journal-title":"J Biol Chem"},{"key":"2849_CR131","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1749-6632.1999.tb09402.x","volume":"886","author":"M Kawabata","year":"1999","unstructured":"Kawabata M, et al. Intracellular signaling of the TGF-beta superfamily by Smad proteins. Ann N Y Acad Sci. 1999;886:73\u201382.","journal-title":"Ann N Y Acad Sci"},{"key":"2849_CR132","first-page":"4479","volume":"9","author":"S Herbertz","year":"2015","unstructured":"Herbertz S, et al. Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway. Drug Des Devel Ther. 2015;9:4479\u201399.","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"2849_CR133","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00280-015-2895-4","volume":"76","author":"Y Fujiwara","year":"2015","unstructured":"Fujiwara Y, et al. Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors. Cancer Chemother Pharmacol. 2015;76(6):1143\u201352.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"2849_CR134","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1111\/liv.14113","volume":"39","author":"S Faivre","year":"2019","unstructured":"Faivre S, et al. Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma. Liver Int. 2019;39(8):1468\u201377.","journal-title":"Liver Int"},{"issue":"5","key":"2849_CR135","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.7150\/ijbs.92988","volume":"20","author":"WX Xu","year":"2024","unstructured":"Xu WX, et al. The burgeoning significance of liquid-liquid phase separation in the pathogenesis and therapeutics of cancers. Int J Biol Sci. 2024;20(5):1652\u201368.","journal-title":"Int J Biol Sci"},{"key":"2849_CR136","doi-asserted-by":"publisher","first-page":"724139","DOI":"10.3389\/fimmu.2022.724139","volume":"13","author":"Q Zou","year":"2022","unstructured":"Zou Q, et al. Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer. Front Immunol. 2022;13:724139.","journal-title":"Front Immunol"},{"issue":"1","key":"2849_CR137","doi-asserted-by":"publisher","first-page":"15040","DOI":"10.1038\/s41598-021-94541-6","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Identification of tumor microenvironment-related prognostic genes in colorectal cancer based on bioinformatic methods. Sci Rep. 2021;11(1):15040.","journal-title":"Sci Rep"},{"key":"2849_CR138","doi-asserted-by":"publisher","first-page":"113877","DOI":"10.1016\/j.jconrel.2025.113877","volume":"384","author":"Z Chen","year":"2025","unstructured":"Chen Z, et al. Dual targeted ferritin-based delivery system blocks the crosstalk between cancer cells and cancer-associated fibroblasts to potentiate immunotherapy of colorectal cancer. J Control Release. 2025;384:113877.","journal-title":"J Control Release"},{"issue":"4","key":"2849_CR139","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.molcel.2021.01.024","volume":"81","author":"W Zhou","year":"2021","unstructured":"Zhou W, et al. cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing. Mol Cell. 2021;81(4):739-755.e7.","journal-title":"Mol Cell"},{"issue":"2","key":"2849_CR140","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.cell.2018.06.026","volume":"174","author":"W Zhou","year":"2018","unstructured":"Zhou W, et al. Structure of the human cGAS-DNA complex reveals enhanced control of immune surveillance. Cell. 2018;174(2):300-311.e11.","journal-title":"Cell"},{"issue":"24","key":"2849_CR141","doi-asserted-by":"publisher","first-page":"11946","DOI":"10.1073\/pnas.1905013116","volume":"116","author":"W Xie","year":"2019","unstructured":"Xie W, et al. Human cGAS catalytic domain has an additional DNA-binding interface that enhances enzymatic activity and liquid-phase condensation. Proc Natl Acad Sci U S A. 2019;116(24):11946\u201355.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"2849_CR142","doi-asserted-by":"publisher","first-page":"e2206820","DOI":"10.1002\/advs.202206820","volume":"10","author":"L Wang","year":"2023","unstructured":"Wang L, et al. Oleic acid dissolves cGAS-DNA phase separation to inhibit immune surveillance. Adv Sci (Weinh). 2023;10(14):e2206820.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"2849_CR143","doi-asserted-by":"publisher","first-page":"2003404","DOI":"10.1002\/advs.202003404","volume":"8","author":"H Zhang","year":"2021","unstructured":"Zhang H, et al. Aldehyde dehydrogenase 2 mediates alcohol-induced colorectal cancer immune escape through stabilizing PD-L1 expression. Adv Sci. 2021;8(10):2003404.","journal-title":"Adv Sci"},{"key":"2849_CR144","doi-asserted-by":"publisher","first-page":"156690","DOI":"10.1016\/j.phymed.2025.156690","volume":"141","author":"Y Xu","year":"2025","unstructured":"Xu Y, et al. Fufang-Biejia-Ruangan tablet targeting both cancer-associated fibroblasts and tumor cells by HIPPO-PI3K\/AKT cascades in intrahepatic cholangiocarcinoma treatment. Phytomedicine. 2025;141:156690.","journal-title":"Phytomedicine"},{"key":"2849_CR145","doi-asserted-by":"publisher","first-page":"1012173","DOI":"10.3389\/fimmu.2022.1012173","volume":"13","author":"X Hu","year":"2022","unstructured":"Hu X, et al. The role of YAP1 in survival prediction, immune modulation, and drug response: a pan-cancer perspective. Front Immunol. 2022;13:1012173.","journal-title":"Front Immunol"},{"key":"2849_CR146","doi-asserted-by":"publisher","first-page":"1053920","DOI":"10.3389\/fimmu.2023.1053920","volume":"14","author":"E Strating","year":"2023","unstructured":"Strating E, et al. Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer. Front Immunol. 2023;14:1053920.","journal-title":"Front Immunol"},{"issue":"1","key":"2849_CR147","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12967-025-06103-3","volume":"23","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. Single-cell and spatial-resolved profiling reveals cancer-associated fibroblast heterogeneity in colorectal cancer metabolic subtypes. J Transl Med. 2025;23(1):175.","journal-title":"J Transl Med"},{"issue":"1","key":"2849_CR148","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cas.15609","volume":"114","author":"Y Yamamoto","year":"2023","unstructured":"Yamamoto Y, et al. The heterogeneity of cancer-associated fibroblast subpopulations: their origins, biomarkers, and roles in the tumor microenvironment. Cancer Sci. 2023;114(1):16\u201324.","journal-title":"Cancer Sci"},{"issue":"1","key":"2849_CR149","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12943-025-02461-0","volume":"24","author":"S Yang","year":"2025","unstructured":"Yang S, et al. Emerging role of cancer-associated fibroblasts in the premetastatic niche. Mol Cancer. 2025;24(1):250.","journal-title":"Mol Cancer"},{"issue":"1","key":"2849_CR150","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13046-025-03496-3","volume":"44","author":"S Di Agostino","year":"2025","unstructured":"Di Agostino S, et al. Proteomic profiling identifies a stromal TGF-\u03b21\/podoplanin axis as a driver of colorectal cancer progression. J Exp Clin Cancer Res. 2025;44(1):247.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"2849_CR151","doi-asserted-by":"publisher","first-page":"189198","DOI":"10.1016\/j.bbcan.2024.189198","volume":"1879","author":"E Chen","year":"2024","unstructured":"Chen E, Zeng Z, Zhou W. The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies. Biochim Biophys Acta Rev Cancer. 2024;1879(6):189198.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5","key":"2849_CR152","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41418-025-01446-2","volume":"32","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, et al. YAP\/TEAD4\/SP1-induced VISTA expression as a tumor cell-intrinsic mechanism of immunosuppression in colorectal cancer. Cell Death Differ. 2025;32(5):911\u201325.","journal-title":"Cell Death Differ"},{"issue":"6","key":"2849_CR153","doi-asserted-by":"publisher","first-page":"e162139","DOI":"10.1172\/JCI162139","volume":"133","author":"WS Ho","year":"2023","unstructured":"Ho WS, et al. PP2Ac\/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages. J Clin Invest. 2023;133(6):e162139.","journal-title":"J Clin Invest"},{"key":"2849_CR154","doi-asserted-by":"publisher","first-page":"1545952","DOI":"10.3389\/fonc.2025.1545952","volume":"15","author":"L Zhang","year":"2025","unstructured":"Zhang L, et al. Hippo\/YAP signaling pathway in colorectal cancer: regulatory mechanisms and potential drug exploration. Front Oncol. 2025;15:1545952.","journal-title":"Front Oncol"},{"key":"2849_CR155","doi-asserted-by":"publisher","first-page":"113998","DOI":"10.1016\/j.jconrel.2025.113998","volume":"385","author":"Y Wu","year":"2025","unstructured":"Wu Y, et al. Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironment. J Control Release. 2025;385:113998.","journal-title":"J Control Release"},{"issue":"10","key":"2849_CR156","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","volume":"187","author":"Z Zong","year":"2024","unstructured":"Zong Z, et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 2024;187(10):2375-2392.e33.","journal-title":"Cell"},{"issue":"8","key":"2849_CR157","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/1878-0261.70006","volume":"19","author":"S Valentini","year":"2025","unstructured":"Valentini S, et al. Targeting the MDM2-MDM4 interaction interface reveals an otherwise therapeutically active wild-type p53 in colorectal cancer. Mol Oncol. 2025;19(8):2412\u201330.","journal-title":"Mol Oncol"},{"issue":"Pt 8","key":"2849_CR158","doi-asserted-by":"publisher","first-page":"127625","DOI":"10.1016\/j.ijbiomac.2023.127625","volume":"253","author":"L Liu","year":"2023","unstructured":"Liu L, et al. Exopolysaccharide from Weissella confusa J4\u20131 inhibits colorectal cancer via induction of cell cycle arrest. Int J Biol Macromol. 2023;253(Pt 8):127625.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"2849_CR159","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s12602-024-10405-1","volume":"17","author":"HKM Leung","year":"2025","unstructured":"Leung HKM, et al. Probiotic mixture attenuates colorectal tumorigenesis in murine AOM\/DSS model by suppressing STAT3, inducing apoptotic p53 and modulating gut microbiota. Probiotics Antimicrob Proteins. 2025;17(4):2227\u201343.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"23","key":"2849_CR160","first-page":"4930","volume":"29","author":"K Chaudagar","year":"2023","unstructured":"Chaudagar K, et al. Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN\/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis. bioRxiv. 2023;29(23):4930\u201340.","journal-title":"bioRxiv"},{"issue":"10","key":"2849_CR161","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1158\/1078-0432.CCR-22-3350","volume":"29","author":"K Chaudagar","year":"2023","unstructured":"Chaudagar K, et al. Reversal of lactate and PD-1-mediated macrophage immunosuppression controls growth of PTEN\/p53-deficient prostate cancer. Clin Cancer Res. 2023;29(10):1952\u201368.","journal-title":"Clin Cancer Res"},{"key":"2849_CR162","doi-asserted-by":"publisher","first-page":"1454587","DOI":"10.3389\/fcell.2024.1454587","volume":"12","author":"J Xu","year":"2024","unstructured":"Xu J, et al. Liquid-liquid phase separation in hepatocellular carcinoma. Front Cell Dev Biol. 2024;12:1454587.","journal-title":"Front Cell Dev Biol"},{"key":"2849_CR163","doi-asserted-by":"publisher","first-page":"107975","DOI":"10.1016\/j.compbiomed.2024.107975","volume":"169","author":"W Peng","year":"2024","unstructured":"Peng W, et al. Liquid-liquid phase separation-related lncRNA prognostic signature and ZNF32-AS2 as a novel biomarker in hepatocellular carcinoma. Comput Biol Med. 2024;169:107975.","journal-title":"Comput Biol Med"},{"issue":"13","key":"2849_CR164","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1016\/j.molcel.2024.06.004","volume":"84","author":"L Wang","year":"2024","unstructured":"Wang L, Zhou W. Phase separation as a new form of regulation in innate immunity. Mol Cell. 2024;84(13):2410\u201322.","journal-title":"Mol Cell"},{"issue":"11","key":"2849_CR165","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.3390\/cancers12113244","volume":"12","author":"R P\u00e9rez-Tom\u00e1s","year":"2020","unstructured":"P\u00e9rez-Tom\u00e1s R, P\u00e9rez-Guill\u00e9n I. Lactate in the tumor microenvironment: an essential molecule in cancer progression and treatment. Cancers (Basel). 2020;12(11):3244.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2849_CR166","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/cas.13928","volume":"110","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, et al. p53\/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53. Cancer Sci. 2019;110(3):939\u201349.","journal-title":"Cancer Sci"},{"issue":"9","key":"2849_CR167","doi-asserted-by":"publisher","first-page":"e004856","DOI":"10.1136\/jitc-2022-004856","volume":"10","author":"Y Ren","year":"2022","unstructured":"Ren Y, et al. Tumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasion. J Immunother Cancer. 2022;10(9):e004856.","journal-title":"J Immunother Cancer"},{"key":"2849_CR168","doi-asserted-by":"publisher","first-page":"115153","DOI":"10.1016\/j.bcp.2022.115153","volume":"202","author":"J Lei","year":"2022","unstructured":"Lei J, et al. Taming metabolic competition via glycolysis inhibition for safe and potent tumor immunotherapy. Biochem Pharmacol. 2022;202:115153.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2849_CR169","first-page":"19","volume":"55","author":"G Luo","year":"2024","unstructured":"Luo G, Zhou C. Latest findings on phase separation of cytomechanical proteins. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024;55(1):19\u201323.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"6","key":"2849_CR170","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.it.2024.04.009","volume":"45","author":"D Liu","year":"2024","unstructured":"Liu D, Yang J, Cristea IM. Liquid-liquid phase separation in innate immunity. Trends Immunol. 2024;45(6):454\u201369.","journal-title":"Trends Immunol"},{"issue":"3","key":"2849_CR171","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41577-021-00572-5","volume":"22","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, McAtee CK, Su X. Phase separation in immune signalling. Nat Rev Immunol. 2022;22(3):188\u201399.","journal-title":"Nat Rev Immunol"},{"key":"2849_CR172","doi-asserted-by":"publisher","first-page":"696234","DOI":"10.3389\/fcell.2021.696234","volume":"9","author":"U Patra","year":"2021","unstructured":"Patra U, M\u00fcller S. A tale of usurpation and subversion: SUMO-dependent integrity of promyelocytic leukemia nuclear bodies at the crossroad of infection and immunity. Front Cell Dev Biol. 2021;9:696234.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2849_CR173","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-024-02013-w","volume":"9","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Membraneless organelles in health and disease: exploring the molecular basis, physiological roles and pathological implications. Signal Transduct Target Ther. 2024;9(1):305.","journal-title":"Signal Transduct Target Ther"},{"key":"2849_CR174","doi-asserted-by":"publisher","first-page":"115474","DOI":"10.1016\/j.colsurfb.2026.115474","volume":"262","author":"Y Liu","year":"2026","unstructured":"Liu Y, et al. CP-31398 restored the functional condensates of R175H p53 by stabilizing the zinc-binding domain and 251\u2013258 segment. Colloids Surf B Biointerfaces. 2026;262:115474.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"2849_CR175","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1021\/acs.biomac.5c01993","volume":"27","author":"H Kaur","year":"2026","unstructured":"Kaur H, et al. Bile acid-induced aggregation and phase separation of mutant p53 leads to doxorubicin sequestration. Biomacromol. 2026;27(3):1891\u2013904.","journal-title":"Biomacromol"},{"issue":"1","key":"2849_CR176","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41421-021-00270-5","volume":"7","author":"Z Qin","year":"2021","unstructured":"Qin Z, et al. Phase separation of EML4-ALK in firing downstream signaling and promoting lung tumorigenesis. Cell Discov. 2021;7(1):33.","journal-title":"Cell Discov"},{"issue":"1","key":"2849_CR177","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molcel.2018.08.027","volume":"72","author":"JJ Bouchard","year":"2018","unstructured":"Bouchard JJ, et al. Cancer mutations of the tumor suppressor SPOP disrupt the formation of active, phase-separated compartments. Mol Cell. 2018;72(1):19-36.e8.","journal-title":"Mol Cell"},{"issue":"17","key":"2849_CR178","doi-asserted-by":"publisher","first-page":"jcs258578","DOI":"10.1242\/jcs.258578","volume":"134","author":"I Owen","year":"2021","unstructured":"Owen I, et al. The oncogenic transcription factor FUS-CHOP can undergo nuclear liquid-liquid phase separation. J Cell Sci. 2021;134(17):jcs258578.","journal-title":"J Cell Sci"},{"issue":"7","key":"2849_CR179","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.tibs.2021.01.002","volume":"46","author":"D Cai","year":"2021","unstructured":"Cai D, Liu Z, Lippincott-Schwartz J. Biomolecular condensates and their links to cancer progression. Trends Biochem Sci. 2021;46(7):535\u201349.","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"2849_CR180","doi-asserted-by":"publisher","first-page":"e202308083","DOI":"10.1083\/jcb.202308083","volume":"223","author":"BD Freibaum","year":"2024","unstructured":"Freibaum BD, et al. Identification of small molecule inhibitors of G3BP-driven stress granule formation. J Cell Biol. 2024;223(3):e202308083.","journal-title":"J Cell Biol"},{"issue":"20","key":"2849_CR181","doi-asserted-by":"publisher","first-page":"jcs261214","DOI":"10.1242\/jcs.261214","volume":"136","author":"K Klement","year":"2023","unstructured":"Klement K, Br\u00fcckner M, Bernkopf DB. Phosphorylation of axin within biomolecular condensates counteracts its tankyrase-mediated degradation. J Cell Sci. 2023;136(20):jcs261214.","journal-title":"J Cell Sci"},{"issue":"34","key":"2849_CR182","doi-asserted-by":"publisher","first-page":"30281","DOI":"10.1021\/acsomega.2c03534","volume":"7","author":"B Xu","year":"2022","unstructured":"Xu B, Chen J, Liu Y. Curcumin interacts with \u03b1-synuclein condensates to inhibit amyloid aggregation under phase separation. ACS Omega. 2022;7(34):30281\u201390.","journal-title":"ACS Omega"},{"issue":"1","key":"2849_CR183","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","volume":"22","author":"SU Khan","year":"2024","unstructured":"Khan SU, et al. Unveiling the mechanisms and challenges of cancer drug resistance. Cell Commun Signal. 2024;22(1):109.","journal-title":"Cell Commun Signal"},{"issue":"12","key":"2849_CR184","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/s41594-023-01159-5","volume":"30","author":"S Basu","year":"2023","unstructured":"Basu S, et al. Rational optimization of a transcription factor activation domain inhibitor. Nat Struct Mol Biol. 2023;30(12):1958\u201369.","journal-title":"Nat Struct Mol Biol"},{"issue":"7","key":"2849_CR185","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","volume":"25","author":"M Hinterndorfer","year":"2025","unstructured":"Hinterndorfer M, et al. Targeted protein degradation for cancer therapy. Nat Rev Cancer. 2025;25(7):493\u2013516.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2849_CR186","first-page":"100413","volume":"4","author":"J Li","year":"2023","unstructured":"Li J, et al. Targeted protein degradation in cancers: orthodox PROTACs and beyond. Innovation (Camb). 2023;4(3):100413.","journal-title":"Innovation (Camb)"},{"issue":"Pt 3","key":"2849_CR187","doi-asserted-by":"publisher","first-page":"117297","DOI":"10.1016\/j.bcp.2025.117297","volume":"242","author":"O Eladl","year":"2025","unstructured":"Eladl O. Molecular glues and PROTACs in targeted protein degradation: mechanisms, advances, and therapeutic potential. Biochem Pharmacol. 2025;242(Pt 3):117297.","journal-title":"Biochem Pharmacol"},{"issue":"48","key":"2849_CR188","doi-asserted-by":"publisher","first-page":"6566","DOI":"10.1038\/s41388-021-02041-8","volume":"40","author":"J Tong","year":"2021","unstructured":"Tong J, et al. BET protein degradation triggers DR5-mediated immunogenic cell death to suppress colorectal cancer and potentiate immune checkpoint blockade. Oncogene. 2021;40(48):6566\u201378.","journal-title":"Oncogene"},{"issue":"3","key":"2849_CR189","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1158\/1535-7163.MCT-24-0444","volume":"24","author":"H Kogai","year":"2025","unstructured":"Kogai H, et al. Broad-spectrum efficacy of CEACAM6-targeted antibody-drug conjugate with BET protein degrader in colorectal, lung, and breast cancer mouse models. Mol Cancer Ther. 2025;24(3):392\u2013405.","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"2849_CR190","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.chembiol.2021.04.009","volume":"28","author":"Z Kozicka","year":"2021","unstructured":"Kozicka Z, Thom\u00e4 NH. Haven\u2019t got a glue: protein surface variation for the design of molecular glue degraders. Cell Chem Biol. 2021;28(7):1032\u201347.","journal-title":"Cell Chem Biol"},{"issue":"3","key":"2849_CR191","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1021\/acs.biochem.1c00464","volume":"62","author":"BP Belcher","year":"2023","unstructured":"Belcher BP, Ward CC, Nomura DK. Ligandability of E3 ligases for targeted protein degradation applications. Biochemistry. 2023;62(3):588\u2013600.","journal-title":"Biochemistry"},{"issue":"11","key":"2849_CR192","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1007\/s11172-022-3659-z","volume":"71","author":"OA Koroleva","year":"2022","unstructured":"Koroleva OA, et al. PROTAC: targeted drug strategy. Principles and limitations Russ Chem Bull. 2022;71(11):2310\u201334.","journal-title":"Principles and limitations Russ Chem Bull"},{"issue":"3","key":"2849_CR193","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.cellin.2023.100092","volume":"2","author":"J Liang","year":"2023","unstructured":"Liang J, et al. Antiviral PROTACs: Opportunity borne with challenge. Cell Insight. 2023;2(3):100092.","journal-title":"Cell Insight"},{"key":"2849_CR194","doi-asserted-by":"publisher","first-page":"217585","DOI":"10.1016\/j.canlet.2025.217585","volume":"616","author":"Z Cheng","year":"2025","unstructured":"Cheng Z, et al. Deciphering the role of liquid-liquid phase separation in sarcoma: Implications for pathogenesis and treatment. Cancer Lett. 2025;616:217585.","journal-title":"Cancer Lett"},{"key":"2849_CR195","doi-asserted-by":"publisher","first-page":"114830","DOI":"10.1016\/j.ejmech.2022.114830","volume":"244","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, et al. Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1. Eur J Med Chem. 2022;244:114830.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"2849_CR196","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0360-3016(97)00469-0","volume":"39","author":"ME Richardson","year":"1997","unstructured":"Richardson ME, Siemann DW. Tumor cell heterogeneity: impact on mechanisms of therapeutic drug resistance. Int J Radiat Oncol Biol Phys. 1997;39(4):789\u201395.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2849_CR197","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.canlet.2012.06.016","volume":"325","author":"JJ Driscoll","year":"2012","unstructured":"Driscoll JJ, Chowdhury RD. Molecular crosstalk between the proteasome, aggresomes and autophagy: translational potential and clinical implications. Cancer Lett. 2012;325(2):147\u201354.","journal-title":"Cancer Lett"},{"issue":"8","key":"2849_CR198","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.1021\/acsnano.4c12747","volume":"19","author":"S Lee","year":"2025","unstructured":"Lee S, Kang S, Kim WJ. Targeted protein degradation in cancer therapy via hydrophobic polymer-tagged nanoparticles. ACS Nano. 2025;19(8):7742\u201354.","journal-title":"ACS Nano"},{"issue":"9","key":"2849_CR199","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1021\/acs.biomac.5c00600","volume":"26","author":"A Rose Galvan","year":"2025","unstructured":"Rose Galvan A, et al. Peptide coacervates can protect sequestered oligonucleotides from nucleases and release them for transcription and translation. Biomacromol. 2025;26(9):5767\u201377.","journal-title":"Biomacromol"},{"issue":"1","key":"2849_CR200","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41420-023-01781-8","volume":"10","author":"Z Cui","year":"2024","unstructured":"Cui Z, et al. Role of protein degradation systems in colorectal cancer. Cell Death Discov. 2024;10(1):141.","journal-title":"Cell Death Discov"},{"issue":"12","key":"2849_CR201","doi-asserted-by":"publisher","first-page":"13511","DOI":"10.1002\/cam4.6020","volume":"12","author":"M Lin","year":"2023","unstructured":"Lin M, et al. TRIM55 inhibits colorectal cancer development via enhancing protein degradation of c-Myc. Cancer Med. 2023;12(12):13511\u201321.","journal-title":"Cancer Med"},{"key":"2849_CR202","doi-asserted-by":"publisher","first-page":"691347","DOI":"10.3389\/fonc.2021.691347","volume":"11","author":"H Su","year":"2021","unstructured":"Su H, et al. Ubiquitin-like protein UBD promotes cell proliferation in colorectal cancer by facilitating p53 degradation. Front Oncol. 2021;11:691347.","journal-title":"Front Oncol"},{"issue":"23","key":"2849_CR203","doi-asserted-by":"publisher","first-page":"15227","DOI":"10.3390\/ijms232315227","volume":"23","author":"YT Zeng","year":"2022","unstructured":"Zeng YT, et al. Different intermolecular interactions drive nonpathogenic liquid-liquid phase separation and potentially pathogenic fibril formation by TDP-43. Int J Mol Sci. 2022;23(23):15227.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2849_CR204","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1021\/acs.biomac.4c00424","volume":"25","author":"X Yu","year":"2024","unstructured":"Yu X, et al. Phase separation enhanced PROTAC for highly efficient protein degradation. Biomacromol. 2024;25(7):4374\u201383.","journal-title":"Biomacromol"},{"issue":"11","key":"2849_CR205","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1007\/s13346-025-01908-7","volume":"15","author":"S Yang","year":"2025","unstructured":"Yang S, Ta YN, Chen Y. Nanotechnology-enhanced immunotherapies for pancreatic ductal adenocarcinoma: challenges and opportunities. Drug Deliv Transl Res. 2025;15(11):4067\u201397.","journal-title":"Drug Deliv Transl Res"},{"issue":"6","key":"2849_CR206","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.nano.2014.04.012","volume":"10","author":"SM Sagnella","year":"2014","unstructured":"Sagnella SM, McCarroll JA, Kavallaris M. Drug delivery: beyond active tumour targeting. Nanomedicine. 2014;10(6):1131\u20137.","journal-title":"Nanomedicine"},{"issue":"12","key":"2849_CR207","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3390\/pharmaceutics16121549","volume":"16","author":"W Meng","year":"2024","unstructured":"Meng W, et al. Innovative nanomedicine delivery: targeting tumor microenvironment to defeat drug resistance. Pharmaceutics. 2024;16(12):1549.","journal-title":"Pharmaceutics"},{"issue":"51","key":"2849_CR208","doi-asserted-by":"publisher","first-page":"e2304654","DOI":"10.1002\/adma.202304654","volume":"35","author":"M Sela","year":"2023","unstructured":"Sela M, et al. Brain-targeted liposomes loaded with monoclonal antibodies reduce alpha-synuclein aggregation and improve behavioral symptoms in Parkinson\u2019s disease. Adv Mater. 2023;35(51):e2304654.","journal-title":"Adv Mater"},{"key":"2849_CR209","doi-asserted-by":"crossref","unstructured":"Maheshwari, S., et al., Advances in Nanotechnology for Targeted Drug Delivery in Alzheimer's Disease. Curr Aging Sci. 2025.","DOI":"10.2174\/0118746098359258250727103551"},{"issue":"1","key":"2849_CR210","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1021\/acsabm.3c00889","volume":"7","author":"Q Liu","year":"2024","unstructured":"Liu Q, et al. Size switchable self-assembled iron oxide aggregations loaded with doxorubicin for deep penetration and enhanced chemotherapy of cancer. ACS Appl Bio Mater. 2024;7(1):297\u2013305.","journal-title":"ACS Appl Bio Mater"},{"key":"2849_CR211","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.actbio.2021.04.022","volume":"134","author":"J Li","year":"2021","unstructured":"Li J, et al. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy. Acta Biomater. 2021;134:546\u201358.","journal-title":"Acta Biomater"},{"issue":"47","key":"2849_CR212","doi-asserted-by":"publisher","first-page":"55913","DOI":"10.1021\/acsami.1c17917","volume":"13","author":"Z Gong","year":"2021","unstructured":"Gong Z, et al. Enzyme-induced transformable peptide nanocarriers with enhanced drug permeability and retention to improve tumor nanotherapy efficacy. ACS Appl Mater Interfaces. 2021;13(47):55913\u201327.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"17","key":"2849_CR213","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1021\/acs.langmuir.1c02390","volume":"38","author":"M Piantino","year":"2022","unstructured":"Piantino M, Nakamoto M, Matsusaki M. Development of highly sensitive molecular blocks at cancer microenvironment for rapid cancer cell death. Langmuir. 2022;38(17):5209\u201317.","journal-title":"Langmuir"},{"issue":"24","key":"2849_CR214","doi-asserted-by":"publisher","first-page":"9716","DOI":"10.3390\/ijms21249716","volume":"21","author":"R Bakhaidar","year":"2020","unstructured":"Bakhaidar R, O\u2019Neill S, Ramtoola Z. PLGA-PEG nanoparticles show minimal risks of interference with platelet function of human platelet-rich plasma. Int J Mol Sci. 2020;21(24):9716.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2849_CR215","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1177\/13872877251374149","volume":"107","author":"G Liu","year":"2025","unstructured":"Liu G, Sun Y. Harnessing nanoparticles for Alzheimer\u2019s disease: Innovations in drug delivery and pathology-specific treatments. J Alzheimers Dis. 2025;107(4):1374\u201399.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2849_CR216","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/pharmaceutics17010036","volume":"17","author":"SS Agrawal","year":"2024","unstructured":"Agrawal SS, Baliga V, Londhe VY. Liposomal formulations: a recent update. Pharmaceutics. 2024;17(1):36.","journal-title":"Pharmaceutics"},{"key":"2849_CR217","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-3-030-78787-5_48","volume":"1339","author":"N Naziris","year":"2021","unstructured":"Naziris N, Demetzos C. Liposomes: production methods and application in Alzheimer\u2019s disease. Adv Exp Med Biol. 2021;1339:385\u201394.","journal-title":"Adv Exp Med Biol"},{"key":"2849_CR218","doi-asserted-by":"publisher","first-page":"1591438","DOI":"10.3389\/fphar.2025.1591438","volume":"16","author":"K Wang","year":"2025","unstructured":"Wang K, et al. Nanocarrier-based targeted drug delivery for Alzheimer\u2019s disease: addressing neuroinflammation and enhancing clinical translation. Front Pharmacol. 2025;16:1591438.","journal-title":"Front Pharmacol"},{"issue":"6","key":"2849_CR219","doi-asserted-by":"publisher","first-page":"e00722","DOI":"10.1016\/j.neurot.2025.e00722","volume":"22","author":"L Chen","year":"2025","unstructured":"Chen L, et al. Engineered nanoplatforms for brain-targeted co-delivery of phytochemicals in Alzheimer\u2019s disease: rational design, blood-brain barrier penetration, and multi-target therapeutic synergy. Neurotherapeutics. 2025;22(6):e00722.","journal-title":"Neurotherapeutics"},{"issue":"Pt 2","key":"2849_CR220","doi-asserted-by":"publisher","first-page":"131514","DOI":"10.1016\/j.ijbiomac.2024.131514","volume":"267","author":"X He","year":"2024","unstructured":"He X, et al. Nucleus-targeting DNase I self-assembly delivery system guided by pirarubicin for programmed multi-drugs release and combined anticancer therapy. Int J Biol Macromol. 2024;267(Pt 2):131514.","journal-title":"Int J Biol Macromol"},{"key":"2849_CR221","doi-asserted-by":"publisher","first-page":"11015","DOI":"10.2147\/IJN.S549893","volume":"20","author":"L Gao","year":"2025","unstructured":"Gao L, Wang J, Bi Y. Nanotechnology for neurodegenerative diseases: recent progress in brain-targeted delivery, stimuli-responsive platforms, and organelle-specific therapeutics. Int J Nanomedicine. 2025;20:11015\u201344.","journal-title":"Int J Nanomedicine"},{"issue":"10","key":"2849_CR222","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2174\/0118715273283338240104112106","volume":"23","author":"J Fatima","year":"2024","unstructured":"Fatima J, Siddique YH. Application of nanocomposites and nanoparticles in treating neurodegenerative disorders. CNS Neurol Disord Drug Targets. 2024;23(10):1217\u201333.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"9","key":"2849_CR223","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1021\/acsabm.0c00917","volume":"3","author":"W Yu","year":"2020","unstructured":"Yu W, Hu C, Gao H. Intelligent size-changeable nanoparticles for enhanced tumor accumulation and deep penetration. ACS Appl Bio Mater. 2020;3(9):5455\u201362.","journal-title":"ACS Appl Bio Mater"},{"key":"2849_CR224","doi-asserted-by":"publisher","first-page":"1210802","DOI":"10.3389\/fimmu.2023.1210802","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, et al. Bibliometric study of immunotherapy for hepatocellular carcinoma. Front Immunol. 2023;14:1210802.","journal-title":"Front Immunol"},{"issue":"8","key":"2849_CR225","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.3390\/cancers12082175","volume":"12","author":"TJ Gardner","year":"2020","unstructured":"Gardner TJ, et al. Targeted cellular micropharmacies: cells engineered for localized drug delivery. Cancers (Basel). 2020;12(8):2175.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2849_CR226","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1021\/acsnano.3c10862","volume":"18","author":"S Sheng","year":"2024","unstructured":"Sheng S, et al. A twindrive precise delivery system of platelet-neutrophil hybrid membrane regulates macrophage combined with CD47 blocking for postoperative immunotherapy. ACS Nano. 2024;18(6):4981\u201392.","journal-title":"ACS Nano"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02849-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02849-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02849-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:55:03Z","timestamp":1781646903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02849-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":226,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2849"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02849-5","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"These issues are not applicable for this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"297"}}